This action might not be possible to undo. Are you sure you want to continue?
More information from http://www.researchandmarkets.com/reports/35229/
Indian Pharmaceutical Industry: Issues and Opportunities
Description: This report provides an in-depth analysis of the Indian Pharmaceutical Industry. Information provided includes: -Characteristics Of The Indian Pharmaceutical Industry -Critical Success Factors For The Industry Player -Research And Development -Industry Structure -Marketing & Distribution In The Pharmaceutical Industry -Future Outlook For The Indian Pharmaceutical Industry
The Key Players In The Indian Pharmaceutical Industry are also examined and Companies Mentioned in this report include: -Aarti Drugs -Abbott India -Ajanta Pharma -Alembic -Astrazeneca Pharma -Aurobindo Pharma -Aventis Pharma -Cadila Health -Cipla -Dr. Reddy -Elder Pharma -German Remedies -Glaxo Smithkline -Ind Swift Lab -Ipca Laboratories -J B Chemical -Jagson Pharma -K D L Biotech -Kopran -Krebs Biochem -Lupin -Lyka Labs -Medicorp Tech -Merck -Natco Pharma -Nicholas Piramal -Novartis -Orchid Chemicals -Organon -Panacea Bio -Pfizer -Pharmacia -Ranbaxy -R P G Life Sciences -Shasun Chemicals -Siris Limited -Sterling Biotech -Strides Arcolab -Sun Pharma -Suven Life Sciences -Torrent Pharma -Unichem Lab
Managed Care Spends .Blockbuster Drugs .Bringing Out A Generic Drug .-Wockhardt -Wyeth Ltd -Zandu Pharma Contents: INTRODUCTION Projected Market Size Break-Up of The Market Key Statistics of The Indian Pharmaceutical Industry Historical Background MARKET OVERVIEW Global Pharmaceutical Sector .Formulations Critical Success Factors .Indian Pharmaceutical Firms Unorganised Sector Collaboration Between Indian Firms And Mncs CRITICAL SUCCESS FACTORS IN THE INDUSTRY Research & Development Production Marketing. Sales And Distribution Operational Efficiency Alliances Critical Success Factors.Multinational Pharmaceutical Firms .Global Expenditure Patterns .Pharmaceutical Products as a Percentage of Healthcare Spending .Analogue or Discovery Research .Generics Gaining Ground .Structural Changes In The Industry CHARACTERISTICS OF THE INDIAN PHARMACEUTICAL INDUSTRY Overview Profitability Patent Reforms Implications of Indian Patent (Amendments) Act. 2005 Cost Advantages Location Risks Traditional Medicine Segmentation of The Indian Pharmaceutical Industry Major Therapeutic Segments Strategic Groups KEY EMERGING TRENDS Organised Sector .Process Research or Reverse Engineering .Biotechnology Research .Ndds Research Pharmaceutical R&D Value Chain .Bulk Drugs Post 2005 Critical Success Factors Critical Success Factors For Indian Companies Critical Success Factors For Mncs RESEARCH AND DEVELOPMENT Kinds of Research .Basic R&D .R&D Expenditures .R&D Capabilities .
Challenges Future Directions FUTURE OUTLOOK FOR THE INDIAN PHARMACEUTICAL INDUSTRY Strategic Options for Indian Firms Entering Overseas Markets Alliance Strategies Patenting Strategies Biotechnology Vaccine Strategies Implications for Mncs Product Patents Industry Profitability Alternative Medicine Emerging Trends .On R&D Implications of The Wto Intellectual Property Rights (Ipr) Changing Scenario of Product Patent Regime Critics View .GATT and WTO Implications of The WTO .Contract Manufacturing .Indian Patents Act 1970 .On Prices of Drugs .R&D Expenditure Technology Conclusion MARKETING & DISTRIBUTION IN THE PHARMACEUTICAL INDUSTRY THE CHANGING EXTERNAL ENVIRONMENT Porters Five Forces Model Threat of New Entrants Intensity of Competition Threat of Substitutes Bargaining Power of Buyers Bargaining Power Of Suppliers PHARMACEUTICAL OUTSOURCING IN INDIA Industry Drivers .Patents Expiry .1970 .Contract Research Clinical Trials Outsourcing .Mnc Dominance .Regulations .R&D In India Changing Scenario of Indian R&D Significant Milestones in Local R&D INDUSTRY STRUCTURE Investments Exports Research and Development Policies and Regulations .Price Escalation .Market Size .R&D Costs .Dpco (Drug Price Control Order) .New Opportunities Pharmaceutical Outsourcing Models .
Aventis Introduction Business Model Products and Services Company Strategy Revenue Break-Up .KEY GROWTH BARRIERS FOR THE INDUSTRY Consolidation Bulk Drug Exports Imports Policy Recommendations INDIAN MEDICAL EQUIPMENTS MARKET Market For Medical Devices Industry Trends Key Market Segments INDIAN HEALTHCARE MARKET Market Overview Key Players .Hinduja Group INDIAN HEALTHCARE BIOTECHNOLOGY MARKET Market Overview Key Players Segmentation of Biotechnology Firms Industry Growth Biopharmaceuticals Bioinformatics Future Developments KEY PLAYERS IN THE INDIAN PHARMACEUTICAL INDUSTRY KEY MNCS .Glaxo Smithkline Introduction Business Model Products and Services Company Strategy Revenue Break-Up .Novartis Introduction Business Model Products and Services .Pfizer Introduction Business Model Products and Services Company Strategy Revenue Break-Up .Apollo Group .Wyeth Introduction Products and Services .Max Healthcare .Merck Introduction Products and Services Company Strategy .
Product Portfolio Company Acquisitions Brand Acquisitions Creating Value Through Functional Strategies .Growth Of Market Share And .European Markets .Revenue Break-Up KEY INDIAN FIRMS IN THE INDIAN PHARMACEUTICAL INDUSTRY .Relationship Marketing .Co-Marketing .Cipla Introduction Business Model Products And Services Company Strategy Revenue Break-Up .Ranbaxy Introduction Business Model Products And Services Company Strategy Revenue Break-Up .1997 Onwards Leveraging Mergers & Alliances .Alliances For Entry Into Us And .1994 – 1997 .Nicholas Piramal India Introduction Business Model Products And Services Company Strategy Revenue Break-Up Introduction Business Model Products And Services Company Strategy Revenue Break-Up .Research And Development .Marketing .Lupin Introduction Business Model Products And Services Company Strategy Revenue Break-Up .Wockhardt Introduction Business Model Products And Services Revenue Break-Up CASE OF A LEADING PHARMACEUTIAL FIRM: RANBAXY LABORATORIES History Ranbaxys Successful Report Card Why Has Ranbaxy Been This Successful? Evolution Of Ranbaxy: Time Line Analysis .1970-Early 1980s Early 1980s-1994 .
Sales Strength ..Invest In Research And Development Capabilities Grow A Wide Product Portfolio Growth Through Mergers And Acquisitions Growth Through Brand Acquisition Growth Through Licensing Agreements Co Marketing Agreement With Competitors Remain A Generics Player How To Build Sustainable Competitive Advantage Product Portfolio Management Integrated Healthcare Company Distribution Disease Management/ Service Provider Clinical Test Centres Healthcare Funding Systems Re-Engineering Outsourcing Services CASE OF A LEADING PHARMACEUTIAL FIRM: DR REDDYS LABS Company Background Branded Generics International Marketing People Management Research & Development Future Tables & Figures List Of Tables Table Table Table Table Table Table Table Table Table Table Table Table Table Table 1: Pharmaceutical Companies In India 2: Leading Therapeutic Segments 3: Market Share Of Major Therapeutic Segments 4: Leading Brands In Major Therapeutic Segments 5: Brand Acquisitions In The Indian Pharmaceutical Industry 6: R&D Investment Of Indian Pharmaceutical Companies 7: Drugs Under Dpco And The Share Of The Industry 8: Where India Stands On Patents 9: Key Players And Their Characteristics 10: Key Brands Of Glaxo Smithkline In India 11: Key Brands Of Pfizer In India 12: Key Brands Of Novartis In India 13: Key Brands Of Aventis In India 14: Key Brands Of Wyeth In India .Brand Recognition Ranbaxys Product Strategy Ranbaxys R&D Strategy Ranbaxys Human Resources Strategy Information Technology REVENUE MODEL FOR A PHARMACEUTICAL COMPANY Strategic Options For Pharmaceutical Firms .
Table Table Table Table Table Table Table Table Table 15: 16: 17: 18: 19: 20: 21: 22: 23: Key Brands Of Merck In India Key Brands Of Ranbaxy Key Brands Of Nicholas Piramal Key Brands Of Dr Reddy’s Key Brands Of Cipla Key Brands Of Lupin Key Brands Of Wockhardt Ranbaxy’s It Initiatives Typical Price Drops After A Drug Goes Off Patent Table Of Figures Figure 1: Projected Size Of Indian Pharmaceutical & Biotechnology Industry Figure 2: Projected Break-Up Of Indian Pharmaceutical & Biotechnology Industry Figure 3: Production Trends Of Pharmaceuticals In India Figure 4: Strategic Group Mapping Of Indian Pharmaceutical Industry Figure 5: Value Added By Pharmaceutical Products Figure 6: Glaxo Smithkline India Product Portfolio Figure 7: Glaxo Smithkline Revenue Break-Up Figure 8: Pfizer India Product Portfolio Figure 9: Merck India Revenue Break-Up Based On Business Segments Figure 10: Ranbaxy Revenue Break-Up Figure 11: Nicholas Piramal Break-Up Of Revenue From Formulations Figure 12: Nicholas Piramal Revenue Break-Up Figure 13: Drl Product Portfolio Figure 14: Lupin Business Profile Figure 15: Lupin Therapeutic Portfolio Figure 16: Distribution Chain Of Pharmaceutical Companies In India Figure 17: Porter’s 5 Forces Model Applied Figure 18: Ranbaxy’s Focus During 1970-Early 1980s Figure 19: Ranbaxy’s Focus During Early 1980s-1994 Figure 20: Ranbaxy’s Focus During 1994-1997 Figure 21: Ranbaxy’s Focus From 1997 Onwards Figure 22: Value Chain Of Ranbaxy Figure 23: Strategic Options Available For Pharmaceutical Firms Ordering: Order Online .com/reports/35229/ Order by Fax .print the order form below and sent to Research and Markets. . Dublin 8. Ireland. Guinness Centre.http://www.using the form below Order by Post . Taylors Lane.researchandmarkets.
: Electronic Enterprisewide: EURO €6.680. Yahoo.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. If you have any questions please visit http://www.Page 1 of 2 Fax Order Form To place an order via fax simply print this form.researchandmarkets.researchandmarkets. Hotmail.00 EURO €25.420. fill in the information below and fax the completed form to 646-6071907 (from USA) or +353-1-481-1716 (from Rest of World). AOL) Mr Mrs Dr Miss Last Name: Ms Prof . Product Name: Web Address: Office Code: Indian Pharmaceutical Industry: Issues and Opportunities http://www.g.com/reports/35229/ OCRMOFFICE Product Formats Please select the product formats and quantity you require: Quantity Electronic .00 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.
to: Research and Markets. Pay by wire transfer: If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets. Ireland. Pay by credit card: American Express Diners Club Master Card Visa Cardholder's Name Cardholder's Signature Expiry Date Card Number CVV Number Issue Date (for Diners Club only) Pay by check: Please post the check. 27-35 Main Street. Co.com/info/terms.From USA +353 1 481 1716 or +353 1 653 1571 . Taylors Lane. Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address 833 130 83 98-53-30 ULSBIE2D IE78ULSB98533083313083 Ulster Bank.Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Guinness Center. Dublin.From Rest of World .asp Please fax this form to: (646) 607-1907 or (646) 964-6609 . Blackrock. Ireland. Dublin 8. accompanied by this form.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue reading from where you left off, or restart the preview.